COPD

The latest of our scientific presentations in the field of stem cell research and treatment.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Early Results Demonstrate Safety and Progress in SMSbiotech’s Human COPD Study

We are pleased to share a significant milestone in SMSbiotech’s ongoing human Phase 1 clinical trial for COPD, currently being conducted in Australia by Veritus Research....

October 22, 2025

Milestone Achievement: First COPD Patient Dosed in Phase 1 Trial

September 17, 2025

Revolutionizing COPD Treatment: Inhaled Small Mobile Stem Cells for Lung Regeneration

August 22, 2025

Discover Breakthrough COPD & Regenerative Medicine Insights at RIS 2025

May 15, 2025

SMSbiotech Featured in News for COPD Therapy

Small Mobile Stem Cell (SMS Cell) — were recently spotlighted in a WBBJ‑TV news story titled “Doctor talks groundbreaking leap in fighting lung disease” as the Pres. of the American Thoracic Society, Pres. of the American Physiological Society, and Division Chief...

May 14, 2025

SMSbiotech Announces Successful Presentation of Small Mobile Stem Cell Regenerative Mechanism in Human COPD Patients at ERS LSC 2025

May 2, 2025

SMSbiotech Receives Green Light for Phase I Clinical Trial in Australia, Targeting COPD

SMSbiotech has secured approval to commence a Phase I clinical trial for COPD in Australia.

March 18, 2025

A Breakthrough in COPD Regeneration: How Small Mobile Stem (SMS) Cells Transform Lung Repair

July 9, 2024

Unveiling Hope: A Potential Breakthrough Treatment for COPD from SMSbiotech

Understanding COPD and our revolutionary approach to treatment

December 8, 2023